Japan Diabetes Devices Market Report 2022 to 2030

Japan Diabetes Devices Market Analysis

$ 3999

Japan's Diabetes Devices Market is expected to witness growth from $1.41 Bn in 2022 to $2.55 Bn in 2030 with a CAGR of 7.70% for the forecasted year 2022-30. Japan has one of the world's oldest populations, with a sizable percentage of the population being over 65. Because older adults have a higher chance of getting diabetes, there is a sizable market for diabetes devices. The market is segmented by type and by the end user. Some key players in this market include Koike Medical, Terumo Corporation, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care, and Dexcom.

ID: IN10JPMD007 CATEGORY: Medical Devices GEOGRAPHY: Japan AUTHOR: Jigyasu Bhandari

Buy Now

Japan Diabetes Devices Healthcare Market Executive Analysis

Japan's Diabetes Devices Market is expected to witness growth from $1.41 Bn in 2022 to $2.55 Bn in 2030 with a CAGR of 7.70% for the forecasted year 2022-30. Japan's healthcare expenditure per individual has improved significantly from $4,360 in 2019, which signified 10.75% of GDP, to $4,450 in 2022, which would represent 10.74% of GDP. The country has an extremely developed healthcare infrastructure due to its high healthcare spending.

In Japan, the prevalence of diabetes is higher among older individuals, with 29.4% of those 75 years or older and 24.4% of those 65 to 74 years old having the disease, respectively. Moreover, 8.2% of males and 6.5% of females are likely to have diabetes, making males more likely than women to have the disease. Diabetes has gradually become more common in Japan. In Japan, 7.6 million individuals between the ages of 20 and 79 had diabetes in 2021, corresponding to a prevalence rate of 7.4%. About 26.4% of Japanese people between the ages of 20 and 79 had prediabetes. Type 1 and type 2 diabetes are the two major subtypes. In Japan, type 2 diabetes makes up the vast bulk of cases; 95% of all diabetes cases are thought to be type 2. Obesity, physical inactivity, and poor diet are all lifestyle factors that have become more common in Japan over the past few years and are usually linked to type 2 diabetes.

In Japan, diabetes devices are essential for managing and treating diabetes. These devices are used to administer insulin, check blood glucose levels, and gauge important health indicators, allowing patients better manage their condition and prevent complications from diabetes. Blood glucose meters, which measure blood glucose levels, can give patients information about their blood sugar levels in real time. Informed decisions about nutrition, exercise, and medication use can be made by patients with the help of this information. It may assist to stop diabetes problems like hypoglycemia and hyperglycemia. Patients have access to real-time information on their blood sugar levels all through the day thanks to wearable devices known as continuous glucose monitoring systems, which continuously measure blood glucose levels.

Japan Diabetes Devices Market Analysis

Market Dynamics

Market Growth Drivers

Japan has one of the world's oldest populations, with a sizable percentage of the population being over 65. Because older adults have a higher chance of getting diabetes, there is a sizable market for diabetes devices and associated goods and services. The growing prevalence of long-term conditions like diabetes has contributed to Japan's consistently rising healthcare expenditure over the past few years. Patients and healthcare professionals are likely to invest more in diabetes devices and associated goods and services as healthcare expenditure keeps rising. The introduction of policies and programs aimed at encouraging healthier lifestyles, enhancing access to diabetes care, and supporting research and development in the area of diabetes management are just a few of the actions the Japanese government has taken to combat the nation's rising diabetes epidemic. By raising demand for diabetes devices and associated products and services, these efforts are likely to support market expansion.

Market Restraints

It may be challenging for manufacturers to enter the diabetes devices market in Japan due to the country's strict laws regarding medical devices. Innovation and market expansion may be hampered by the time-consuming and expensive regulatory clearance procedure for new devices. Diabetes device sales in Japan are fiercely competitive, with both established businesses and more recent newcomers fighting for the top spot. It might be hard for manufacturers to differentiate themselves from rivals and win the diabetes devices market in Japan.

Competitive Landscape

Key Players

Koike Medical (JP)
Terumo Corporation (JP)
Fukuda (JP)
Johnson & Johnson
Medtronic
Roche
Dexcom
Ascensia Diabetes Care

Recent Notable Deals

2022: In 2022, Terumo disclosed officially its purchase of Becton Dickinson's diabetes care business. The acquisition allowed Terumo to strengthen its reputation in the Japanese market and broaden the scope of its diabetes care services.

Healthcare Policies and Regulatory Landscape

In Japan, the market control for diabetes devices is supervised by the Ministry of Health, Labour, and Welfare (MHLW). Medical devices, such as insulin pumps, continuous glucose monitoring systems, blood glucose meters, and other connected goods, are subject to the Pharmaceutical Affairs Law and other regulations. The MHLW has developed several policies and regulations to ensure the safety and efficacy of diabetes gadgets in Japan. Clinical studies that must be conducted, standards for quality assurance, and product approvals are just a few of the topics covered by these laws. In order to watch the effectiveness and security of diabetes devices, the MHLW also conducts post-marketing monitoring. In order to promote the use of diabetes devices and improve patient outcomes, the Japanese government has implemented a number of policies in addition to regulatory standards. A national diabetes prevention initiative, for instance, was established by the government to reduce the prevalence of diabetes and promote healthy lifestyle choices. Thanks to established government reimbursement guidelines, patients can now more easily acquire diabetes devices.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Diabetes Devices Market Segmentation

By Type (Revenue, USD Billion):

The market is divided into blood glucose monitoring systems, insulin delivery systems, and mobile applications for managing diabetes within the type segment. Due to its convenience, ease of use, and usefulness in providing patients and healthcare professionals with real-time insights regarding diabetic conditions for integrated diabetes management, the segment for diabetes management mobile applications is anticipated to grow at the highest rate during the forecast period. Bare-metal Stents

Blood glucose monitoring systems
Self-monitoring blood glucose monitoring systems
Continuous glucose monitoring systems
Test strips/Test papers
Lancets/Lancing Devices
Insulin delivery Devices
Insulin pumps
Insulin pens
Insulin syringes and needles
Diabetes management mobile applications

By End User (Revenue, USD Billion):

The diabetes market is divided into hospitals & specialty clinics and self & home care, based on the end user.

Hospitals & Specialty Clinics
Self & Home Care

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.